EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Towards Personalized Chemotherapy in Gastrointestinal Cancers: Prospective Analysis of Pharmacogenetic Variants in a Russian Cohort

Denis Fedorinov iD, Vladimir Lyadov iD, Marina Lyadova iD, Sherzod Abdullaev iD, Anastasia Kachanova iD, Rustam Heydarov iD, Igor Shashkov iD, Sergey Surzhikov iD, Vladimir Mikhailovich iD, Dmitry Sychev iD

Genes · 2025

DOI: 10.3390/genes16111261 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Genes, 2025. Verfasst von Denis Fedorinov und 9 weiteren Autor:innen. Beteiligte Einrichtung: Federal State Budgetary Educational Institution, Further Professional Education "Russian Medical Academy of Continuous Professional Education", the M…. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Precision Medicine, Pharmacogenomic Variants. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Pharmacogenetic variability plays a crucial role in determining both the efficacy and toxicity of chemotherapy for gastrointestinal cancers. However, data on allele frequencies and their clinical relevance in Russian populations remain scarce.

Methods

We conducted a prospective observational study of 412 patients with gastrointestinal malignancies between 2020 and 2023. Pharmacogenetic testing was performed prior to the initiation of chemotherapy using real-time allele-specific PCR and microarray hybridization technology. Polymorphisms in the DPYD, UGT1A1, CYP2C8, CYP3A5, GSTP1, ERCC1, XPC, CDA, MTHFR, TYMS, and SLC31A1 genes were analyzed.

Results

The frequency of most variants was consistent with those reported in European populations, reflecting the ethnic proximity of the studied cohort. Several clinically relevant variants were identified: DPYD rs2297595 occurred more frequently than in European cohorts, and UGT1A1 rs8175347 was observed at a higher prevalence, underscoring the potential risk of irinotecan-related neutropenia and diarrhea. CYP2C8 rs10509681 was present at frequencies comparable to European populations and is associated with an increased risk of taxane-induced peripheral neuropathy. Other markers (GSTP1, ERCC1, CDA, SLC31A1, MTHFR, TYMS) demonstrated variable associations with chemotherapy efficacy and toxicity, consistent with findings from previous international studies.

Conclusions

This study provides the first comprehensive description of pharmacogenetic polymorphisms in a Russian cohort of patients with gastrointestinal cancers. Our findings confirm the clinical importance of DPYD and UGT1A1 testing and highlight additional variants of potential interest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal NeoplasmsPrecision MedicinePharmacogenomic VariantsHumansMaleFemaleMiddle AgedProspective StudiesRussiaAgedAdultPolymorphism, Single NucleotideGene FrequencyGlucuronosyltransferasePharmacogenomic TestingPharmacogeneticsUGT1A1 Enzyme

Stichwörter der Autor:innen

DPYDUGT1A1cancergenegeneticsgenomegenotypepharmacogeneticspharmacogenomics

Substanzen

GlucuronosyltransferaseUGT1A1 Enzyme

Autor:innen und Institutionen

  • Federal State Budgetary Educational Institution, Further Professional Education "Russian Medical Academy of Continuous Professional Education", the Ministry of Healthcare of the Russian Federation, 123242 Moscow, Russia.
  • Moscow Multidisciplinary Clinical Center "Kommunarka", 142770 Moscow, Russia.
  • Federal State Budgetary Research Institution «Russian Research Center of Surgery Named After Academician B.V. Petrovsky», 119991 Moscow, Russia.
  • Moscow State Budgetary Healthcare Institution "Oncological Center No. 1 of Moscow City Hospital Named After S.S. Yudin, Moscow Healthcare Department", 115446 Moscow, Russia.
  • Novokuznetsk State Institute of Postgraduate Medical Education-Branch of Russian Medical Academy of Continuous Professional Education, 654000 Novokuznetsk, Russia.
  • Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.

ORCID-Profile: Denis Fedorinov, Vladimir Lyadov, Marina Lyadova, Sherzod Abdullaev, Anastasia Kachanova, Rustam Heydarov, Igor Shashkov, Sergey Surzhikov, Vladimir Mikhailovich, Dmitry Sychev

Förderung

  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Fedorinov, D., Lyadov, V., Lyadova, M., Abdullaev, S., Kachanova, A., Heydarov, R., Shashkov, I., Surzhikov, S., Mikhailovich, V., & Sychev, D. (2025). Towards Personalized Chemotherapy in Gastrointestinal Cancers: Prospective Analysis of Pharmacogenetic Variants in a Russian Cohort. Genes. https://doi.org/10.3390/genes16111261

Vancouver

Fedorinov D, Lyadov V, Lyadova M, Abdullaev S, Kachanova A, Heydarov R, et al. Towards Personalized Chemotherapy in Gastrointestinal Cancers: Prospective Analysis of Pharmacogenetic Variants in a Russian Cohort. Genes. 2025. doi:10.3390/genes16111261

BibTeX
@article{Fedorinov2025,
  author = {Fedorinov, Denis and Lyadov, Vladimir and Lyadova, Marina and Abdullaev, Sherzod and Kachanova, Anastasia and Heydarov, Rustam and Shashkov, Igor and Surzhikov, Sergey and Mikhailovich, Vladimir and Sychev, Dmitry},
  title = {Towards Personalized Chemotherapy in Gastrointestinal Cancers: Prospective Analysis of Pharmacogenetic Variants in a Russian Cohort},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16111261}
}
Kostenlos starten →